GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Additional Paid-In Capital

BioDelivery Sciences International (FRA:BD5) Additional Paid-In Capital : €403.5 Mil(As of Dec. 2021)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Additional Paid-In Capital?


BioDelivery Sciences International's quarterly additional paid-in capital increased from Jun. 2021 (€375.6 Mil) to Sep. 2021 (€386.5 Mil) and increased from Sep. 2021 (€386.5 Mil) to Dec. 2021 (€403.5 Mil).

BioDelivery Sciences International's annual additional paid-in capital declined from Dec. 2019 (€392.7 Mil) to Dec. 2020 (€369.3 Mil) but then increased from Dec. 2020 (€369.3 Mil) to Dec. 2021 (€403.5 Mil).


BioDelivery Sciences International Additional Paid-In Capital Historical Data

The historical data trend for BioDelivery Sciences International's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Additional Paid-In Capital Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 265.26 334.90 392.68 369.30 403.47

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 369.30 378.67 375.62 386.53 403.47

BioDelivery Sciences International Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

BioDelivery Sciences International Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines